Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

The 436-amino acid protein enolase 1 from yeast was degraded in vitro by purified wild-type and mutant yeast 20S proteasome particles. Analysis of the cleavage products at different times revealed a processive degradation mechanism and a length distribution of fragments ranging from 3 to 25 amino acids with an average length of 7 to 8 amino acids. Surprisingly, the average fragment length was very similar between wild-type and mutant 20S proteasomes with reduced numbers of active sites. This implies that the fragment length is not influenced by the distance between the active sites, as previously postulated. A detailed analysis of the cleavages also allowed the identification of certain amino acid characteristics in positions flanking the cleavage site that guide the selection of the P1 residues by the three active beta subunits. Because yeast and mammalian proteasomes are highly homologous, similar cleavage motifs might be used by mammalian proteasomes. Therefore, our data provide a basis for predicting proteasomal degradation products from which peptides are sampled by major histocompatibility complex class I molecules for presentation to cytotoxic T cells.

[1]  Alexei F. Kisselev,et al.  Processive Degradation of Proteins and Other Catalytic Properties of the Proteasome from Thermoplasma acidophilum* , 1997, The Journal of Biological Chemistry.

[2]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[3]  B. Dahlmann,et al.  Subunit arrangement in the human 20S proteasome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Orłowski,et al.  A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex. , 1992, Biochemistry.

[5]  Wolfgang Baumeister,et al.  Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System , 1997 .

[6]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[7]  S Karlin,et al.  Methods and algorithms for statistical analysis of protein sequences. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Altman,et al.  Multiple significance tests: the Bonferroni method , 1995, BMJ.

[9]  P M Kloetzel,et al.  A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.

[10]  Alexei F. Kisselev,et al.  Range of Sizes of Peptide Products Generated during Degradation of Different Proteins by Archaeal Proteasomes* , 1998, The Journal of Biological Chemistry.

[11]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[12]  K Eichmann,et al.  The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Orłowski,et al.  Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. , 1989, Biochemistry.

[14]  R. Huber,et al.  Conformational constraints for protein self-cleavage in the proteasome. , 1998, Journal of molecular biology.

[15]  E. Shaw,et al.  Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes. , 1993, The Biochemical journal.

[16]  G N DeMartino,et al.  Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome). , 1991, Biochemistry.

[17]  A. Ciechanover,et al.  Ubiquitin-dependent Degradation of Certain Protein Substrates in Vitro Requires the Molecular Chaperone Hsc70* , 1997, The Journal of Biological Chemistry.

[18]  Clive A. Slaughter,et al.  Proteolytic Processing of Ovalbumin and β-galactosidase by the Proteasome to Yield Antigenic Peptides , 1994 .

[19]  G N DeMartino,et al.  The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes. , 1989, Biochimica et biophysica acta.

[20]  M. Bevan,et al.  Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. , 1989, Journal of immunology.

[21]  Hans-Georg Rammensee,et al.  A role for the proteasome regulator PA28α in antigen presentation , 1996, Nature.

[22]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[23]  J. M. Zimmerman,et al.  The characterization of amino acid sequences in proteins by statistical methods. , 1968, Journal of theoretical biology.

[24]  K. Ferrell,et al.  Purification of an 11 S regulator of the multicatalytic protease. , 1992, The Journal of biological chemistry.

[25]  C. Slaughter,et al.  Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). , 1992, The Journal of biological chemistry.

[26]  W. Baumeister,et al.  Existence of a molecular ruler in proteasomes suggested by analysis of degradation products , 1994, FEBS letters.

[27]  M. Levitt.  Conformational preferences of amino acids in globular proteins. , 1978, Biochemistry.

[28]  A. Rivett,et al.  Catalytic Properties of 26 S and 20 S Proteasomes and Radiolabeling of MB1, LMP7, and C7 Subunits Associated with Trypsin-like and Chymotrypsin-like Activities* , 1997, The Journal of Biological Chemistry.

[29]  D. Wolf,et al.  The Active Sites of the Eukaryotic 20 S Proteasome and Their Involvement in Subunit Precursor Processing* , 1997, The Journal of Biological Chemistry.